For many investors, the main point of stock picking is to generate higher returns than the overall market. But its virtually certain that sometimes you will buy stocks that fall short of the market average returns. Unfortunately, that’s been the case for longer term Oceania Healthcare Limited (NZSE:OCA) shareholders, since the share price is down 43% in the last three years, falling well short of the market decline of around 2.1%. Furthermore, it’s down 20% in about a quarter. That’s not much fun for holders.

It’s worthwhile assessing if the company’s economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let’s do just that.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it’s a weighing machine. One way to examine how market sentiment has changed over time is to look at the interaction between a company’s share price and its earnings per share (EPS).

Over the three years that the share price declined, Oceania Healthcare’s earnings per share (EPS) dropped significantly, falling to a loss. Since the company has fallen to a loss making position, it’s hard to compare the change in EPS with the share price change. But it’s safe to say we’d generally expect the share price to be lower as a result!

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

This free interactive report on Oceania Healthcare’s earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

We’ve already covered Oceania Healthcare’s share price action, but we should also mention its total shareholder return (TSR). The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Dividends have been really beneficial for Oceania Healthcare shareholders, and that cash payout explains why its total shareholder loss of 40%, over the last 3 years, isn’t as bad as the share price return.

While the broader market gained around 4.6% in the last year, Oceania Healthcare shareholders lost 6.3%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Regrettably, last year’s performance caps off a bad run, with the shareholders facing a total loss of 3% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We’ve spotted 1 warning sign for Oceania Healthcare you should be aware of.